Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MIDOSTAURIN vs MIFEPRISTONE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MIDOSTAURIN vs MIFEPRISTONE: Safety Overview

Metric MIDOSTAURIN MIFEPRISTONE
Total FAERS Reports 2,993 4,492
Deaths Reported 694 294
Death Rate 23.2% 6.5%
Hospitalizations 918 1,322
Average Patient Age 53.3 yrs 46.2 yrs
% Female Patients 45.5% 84.4%
FDA Approval Date Apr 28, 2017 Apr 11, 2019
Manufacturer Novartis Pharmaceuticals Corporation Corcept Therapeutics Incorporated
Route ORAL ORAL
Marketing Status Prescription Prescription